Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors.
about
Natural killer cell responses during viral infections: flexibility and conditioning of innate immunity by experienceCell biological steps and checkpoints in accessing NK cell cytotoxicityTumor-primed NK cells: waiting for the green lightRemodelling of cortical actin where lytic granules dock at natural killer cell immune synapses revealed by super-resolution microscopyProtein Kinase Inhibitors CK59 and CID755673 Alter Primary Human NK Cell Effector FunctionsCytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2AKinome analysis of receptor-induced phosphorylation in human natural killer cellsNKp46 Clusters at the Immune Synapse and Regulates NK Cell Polarization.Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab')2Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligaseRegulation of human NK-cell cytokine and chemokine production by target cell recognition.Innate immune natural killer cells and their role in HIV and SIV infection.XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus.Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu.Balancing natural killer cell activation through paired receptors.Ras-related C3 Botulinum Toxin Substrate (Rac) and Src Family Kinases (SFK) Are Proximal and Essential for Phosphatidylinositol 3-Kinase (PI3K) Activation in Natural Killer (NK) Cell-mediated Direct Cytotoxicity against Cryptococcus neoformans.Super-resolution imaging of remodeled synaptic actin reveals different synergies between NK cell receptors and integrins.Antibody Fc engineering improves frequency and promotes kinetic boosting of serial killing mediated by NK cells.Inhibitory signaling blocks activating receptor clustering and induces cytoskeletal retraction in natural killer cellsORAI1-mediated calcium influx is required for human cytotoxic lymphocyte degranulation and target cell lysisA single amino acid change in inhibitory killer cell Ig-like receptor results in constitutive receptor self-association and phosphorylation.NK-cell-dependent killing of colon carcinoma cells is mediated by natural cytotoxicity receptors (NCRs) and stimulated by parvovirus infection of target cells.Natural killer cell responses to viral infection.NKG2D is a Key Receptor for Recognition of Bladder Cancer Cells by IL-2-Activated NK Cells and BCG Promotes NK Cell ActivationGenetic Manipulation of NK Cells for Cancer Immunotherapy: Techniques and Clinical Implications.The adaptor protein Crk controls activation and inhibition of natural killer cells.Generation and preclinical characterization of an NKp80-Fc fusion protein for redirected cytolysis of natural killer (NK) cells against leukemiaThe MICA-129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantation.Structural insights into activation of antiviral NK cell responsesHuman NK cell lytic granules and regulation of their exocytosisSignaling for synergistic activation of natural killer cells.Natural killer cells: multifaceted players with key roles in hepatitis C immunity.Cutting edge: NK cell licensing modulates adhesion to target cellsLytic granule polarization, rather than degranulation, is the preferred target of inhibitory receptors in NK cells.Complementary phosphorylation sites in the adaptor protein SLP-76 promote synergistic activation of natural killer cellsCutting edge: NKG2D-dependent cytotoxicity is controlled by ligand distribution in the target cell membrane.Tethering of intercellular adhesion molecule on target cells is required for LFA-1-dependent NK cell adhesion and granule polarization.Controlling natural killer cell responses: integration of signals for activation and inhibition.Human immunodeficiency syndromes affecting human natural killer cell cytolytic activity.Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency
P2860
Q26850968-6A85989B-3F9C-49D8-A7F2-8CC72ED92D6EQ26852411-650B05B4-F869-4AB6-ACC3-8168484B01D0Q26999306-8EFFB2D4-B016-4A76-8065-9895962A30EFQ27320914-3A5AB248-B31E-41BC-9A4D-D939E79DB753Q28703128-2C7D0D70-E43A-4A2B-B78B-74C084677231Q28731856-292CB47A-2F7B-45A3-9CAC-BFBB7265F84DQ28740357-20836037-C862-4DA0-B4CA-1FDDFF784910Q30665729-2B93BA9D-7511-416A-86EA-A30DFAAB2F32Q33664396-DCD4138F-5D5A-49DD-B9FD-5BF7A7AA3FE7Q33745662-B15017AF-DF5F-4BC0-B5AB-A3C0654FA350Q33747309-55F08361-4F51-4605-89D6-C9D2B9AEBF82Q34070433-F4A6A3EB-44FE-4B61-B10E-059E726E7AA6Q34405170-C6B0E961-2F70-42D8-A1F0-709541DEEAE3Q34423336-23276964-19A9-47A3-B0D3-A6CDCAEC7CDDQ34465877-7459E809-A7E9-4A54-99D7-3C8F9C7274CAQ34513569-B8A6FEDF-973C-4780-8C9F-0B11FE995753Q34548289-D135EFA7-D2EC-4261-BB04-5878787D0520Q34551199-3BA30FFA-A980-497A-A534-F8B197295343Q34600774-426185E9-1AEA-4B8C-A2C5-88A9E9E73AF6Q34602870-41C405CE-1D8A-4DA4-AF59-8F61026A1568Q34810583-609D4445-ACF8-4FFD-9B6F-852CBE6D14FEQ34884713-6E6074A5-57DA-478E-B24B-A071699E63E8Q35082268-0B09BBBC-E0D7-4972-94F6-9AC9741D0336Q35693194-4F508CBB-9898-4D96-919A-8B3D8F72E16FQ35711209-5771005B-7FCC-4E0C-BA10-A2D93909490EQ35971591-1132018D-76D3-4139-AEDA-9D87AF9041BDQ36049914-F33D6577-EB7C-4C32-88D1-906C4511C41EQ36278732-78B334F7-6E2D-45C4-8030-5AD1B4C7A5F0Q36317668-5018185E-5979-4044-AB77-E885E1CFAE80Q36386541-E05DD09A-43C7-48F0-B302-91BF51DB5AC3Q36592767-7EFC00A1-8848-437A-8349-27A9B7488EF5Q37151472-AB435F02-8FE4-4F19-8ECD-06D76748E0F6Q37227962-DB55C68D-169A-4859-834D-B9CA0521108AQ37346605-B64F2A04-5D67-4815-85E6-5949171DD58BQ37346641-52240310-68A5-489B-ACB7-EF0804D04689Q37398391-8DCB2F2A-8B65-4C2D-877E-0B4AA6345C85Q37403050-F5745EC8-084F-4F41-B8C0-15F95D5BB099Q37404156-BFFD37E9-98A3-4B5E-A267-57B172339A9AQ37497535-DD267FA8-0CAD-404E-920B-344B6759F774Q37549738-3043E263-4CF0-47DE-ACC9-130FC90521E5
P2860
Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Minimal requirement for induct ...... gnals by inhibitory receptors.
@en
Minimal requirement for induct ...... gnals by inhibitory receptors.
@nl
type
label
Minimal requirement for induct ...... gnals by inhibitory receptors.
@en
Minimal requirement for induct ...... gnals by inhibitory receptors.
@nl
prefLabel
Minimal requirement for induct ...... gnals by inhibitory receptors.
@en
Minimal requirement for induct ...... gnals by inhibitory receptors.
@nl
P2860
P1433
P1476
Minimal requirement for induct ...... ignals by inhibitory receptors
@en
P2093
Eric O Long
Hans-Gustaf Ljunggren
P2860
P304
P356
10.1182/BLOOD-2009-01-201632
P407
P577
2009-07-23T00:00:00Z